TCL Archive FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts October 9, 1981
TCL Archive In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit December 18, 2009
TCL Archive Congressional committee investigates former NCI Director Richard Klausner’s role in $40 million Harvard contract; NIH begins internal review. Klausner: investigation casts “strange innuendoes.” Text of committee’s letter. November 14, 2003